Infectious agents, inflammation, and growth factors: How do they interact in the progression or stabilization of mild human atherosclerotic lesions?

Annals of Vascular Surgery

Volumn 20, Issue 5, 2006, Pages 638-645

  Góis, José ^a   Higuchi, Maria ^a   Reis, Márcia ^a   Diament, Jayme ^a   Sousa, Januário ^a   Ramires, José ^a   Oliveira, Sérgio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIBODY; CD4 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR B; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; ASCENDING AORTA; ATHEROMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; B LYMPHOCYTE; CD20+ B CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFECTION; INFLAMMATION; INFLAMMATORY CELL; LYMPHOCYTE; MACROPHAGE; MALE; MOLECULAR INTERACTION; PATHOGENESIS; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; SUBENDOTHELIUM; T LYMPHOCYTE;

EID: 33845616286     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10016-006-9076-1     Document Type: Article

References (23)

1. Ross R. Atherosclerosis. An inflammatory disease. N Engl J Med 1999;340:115-126.
2. Raines EW. PDGF and cardiovascular disease. Cytokine Growth Factor Rev 2004;15:237-254.
3. Rutherford RB, Ross R. Platelet factors stimulate fibroblasts and smooth muscle cells quiescent in plasma serum to proliferate. J Cell Biol 1976;69:196-203.
4. Libby P. The vascular biology of atherosclerosis In: Zipes, D, Libby, P, Bonow, RO, Braunwald, E, eds Braunwald's Heart Disease. 7th ed. Philadelphia: Elsevier Saunders, 2005, pp 921-937.
5. Shor A, Phillips JI. Chlamydia pneumoniae and atherosclerosis. JAMA. 1999;282:2071-2073.
6. Gupta S. Chronic infection in the aetiology of atherosclerosis - focus on Chlamydia pneumoniae. Atherosclerosis 1999;143:1-6.
7. O'Connor S, Taylor D, Campbell LA, et al. Potential infectious etiologies of atherosclerosis: a multifactorial perspective. Emerg Infect Dis 2001;7:780.
8. Mahony JB, Coombes BK. Chlamydia pneumoniae and atherosclerosis: does the evidence support a causal or contributory role?. FEMS Microbiol Lett 2001;197:1-9.
9. Higuchi ML, Sambiase NV, Palomino S, et al. Detection of Mycoplasma pneumoniae and Chlamydia pneumoniae in ruptured atherosclerotic plaques. Braz. J Med Biol Res 2000;33:1023-1026.
10. Higuchi ML, Reis MM, Sambiase NV, et al. Coinfection with Mycoplasma pneumoniae and Chlamydia pneumoniae in ruptured plaques associated with acute myocardial infarction. Arq Bras Cardiol 2003;81:12-22.
11. Raines EW. PDGF and cardiovascular disease. Cytokine Growth Factor Rev 2004;15:237-254.
12. Barrett TB, Benditt EP. Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. Proc Natl Acad Sci USA 1988;85:2810-2814.
13. Vink A, Poppen M, Schoneveld AH, et al. Distribution of Chlamydia pneumoniae in the human arterial system and its relation to the local amount of atherosclerosis within the individual. Circulation 2001;103:1613-1617.
14. Razin S, Yogev D, Naot Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol. Mol Biol Rev 1998;62:1094-1156.
15. Pietsch K, Ehlers S, Jacobs E. Cytokine gene expression in the lungs of BALB/c mice during primary and secondary intranasal infection with Mycoplasma pneumoniae. Microbiology 1994;140:2043-2048.
16. Ross R. Atherosclerosis. An inflammatory disease. N Engl J Med 1999;340:115-126.
17. Dunbar LM. Current issues in the management of bacterial respiratory tract disease: the challenge of antibacterial resistance. Am J Med Sci 2003;326:360-368.
18. Hammerschlag MR. Advances in the management of Chlamydia pneumoniae infections. Exp Rev Anti Infect Ther 2003;1:493-503.
19. Kutlin A, Kohlhoff S, Roblin P, Hammerschlag MR, Riska P. Emergence of resistance to rifampin and Rifalazil in Chlamydophila pneumoniae and Chlamydia trachomatis. Antimicrob. Agents Chemother 2005;49:903-907.
20. Bezerra HG, Higuchi ML, Gutierrez OS, et al. Atheromas that cause fatal thrombosis are usually large and frequently accompanied by vessel enlargement. Cardiovasc Pathol 2001;10:189-196.
21. Inoue I, Inaba T, Motoyoshi K, et al. Macrophage colony stimulating factor prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Atherosclerosis 1992;93:245-254.
22. Nyskanen AI, Krebs R, Tikkanen JM, et al. Combined vascular endothelial growth factor and platelet derived growth factor inhibition in rat cardiac allografts: beneficial effects on inflammation and smooth muscle cell proliferation. Transplantation 2005;79:182-189.
23. Prochnau D, Rodel J, Hartmann M, Straube E, Figulla HR. Growth factor production in human endothelial cells after Chlamydia pneumoniae infection. Int J Med Microbiol 2004;294:53-57.